DCLRE1C Gene Severe Combined Immunodeficiency Athabascan Type NGS Genetic DNA Test
Comprehensive Genetic Testing for Severe Immune Disorders
The DCLRE1C Gene Severe Combined Immunodeficiency Athabascan Type NGS Genetic DNA Test represents a breakthrough in precision medicine for diagnosing inherited immune system disorders. This advanced genetic screening utilizes next-generation sequencing (NGS) technology to identify specific mutations in the DCLRE1C gene that are associated with severe combined immunodeficiency (SCID) in Athabascan populations. Early detection through this comprehensive test can be life-saving, enabling timely interventions and personalized treatment approaches.
What Does This Test Measure?
This specialized genetic test specifically targets and analyzes the DCLRE1C gene, which plays a critical role in DNA repair and V(D)J recombination – essential processes for developing a functional immune system. The test detects:
- Pathogenic mutations in the DCLRE1C gene associated with SCID
- Specific genetic variants common in Athabascan populations
- DNA sequence variations affecting immune cell development
- Inheritance patterns of immunodeficiency disorders
- Risk assessment for future generations
Who Should Consider This Test?
This genetic test is particularly recommended for individuals experiencing:
- Recurrent, severe, or unusual infections in infancy or childhood
- Family history of severe combined immunodeficiency
- Athabascan ancestry with concerns about inherited immune disorders
- Unexplained failure to thrive in infants
- Persistent diarrhea, pneumonia, or fungal infections
- Delayed immune system development
- Autoimmune manifestations alongside immune deficiency
Key Benefits of DCLRE1C Genetic Testing
Undergoing this comprehensive genetic analysis provides numerous advantages:
- Early Diagnosis: Enables prompt intervention before life-threatening complications develop
- Personalized Treatment: Guides targeted therapeutic approaches including bone marrow transplantation
- Family Planning: Provides crucial information for reproductive decisions and genetic counseling
- Proactive Management: Allows for preventive measures and specialized medical care
- Improved Outcomes: Significantly enhances survival rates and quality of life
Understanding Your Test Results
Our comprehensive genetic counseling services help you interpret your results effectively:
- Positive Result: Indicates presence of DCLRE1C gene mutation; immediate consultation with immunology specialists recommended
- Negative Result: No detected mutations; however, continued monitoring may be advised based on clinical presentation
- Variant of Uncertain Significance: Requires additional family studies and ongoing research correlation
- Carrier Status: Important information for family planning and genetic counseling
Test Pricing and Details
| Test Feature | Details |
|---|---|
| Test Name | DCLRE1C Gene Severe Combined Immunodeficiency Athabascan Type NGS Genetic DNA Test |
| Regular Price | $700 USD |
| Discount Price | $500 USD |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type | Blood, Extracted DNA, or One Drop Blood on FTA Card |
Nationwide Testing Availability
GGC DNA provides comprehensive genetic testing services across the United States, with convenient locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art laboratories ensure accurate results and timely delivery.
Take Control of Your Health Today
Don’t wait to get the critical genetic information you need for informed healthcare decisions. Our team of genetic specialists, immunologists, and counselors are ready to support you through every step of the testing process. Early detection of DCLRE1C gene mutations can significantly improve treatment outcomes and quality of life.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your DCLRE1C Genetic DNA Test and take the first step toward personalized immune health management.
